Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: A long-term follow-up study

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Tofik, Rafid ^a   Ohlsson, Sophie ^a   Bakoush, Omran ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; BLOOD SAMPLING; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROSCLEROSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; TREATMENT OUTCOME;

EID: 84900414837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087857     Document Type: Article

References (30)

1. Rovin BH, Doe N, Tan LC (1996) Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27: 640-646. (Pubitemid 26135835)
2. Lepenies J, Eardley KS, Kienitz T, Hewison M, Ihl T, et al. (2011) Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-beta in patients with chronic kidney disease. Nephron Clin Pract 119: c97-c104.
3. Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, et al. (2010) Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta 411: 700-704.
4. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, et al. (2003) Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 14: 1066-1071. (Pubitemid 36359289)
5. Kulkarni O, Pawar RD, Purschke W, Eulberg D, Selve N, et al. (2007) Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. J Am Soc Nephrol 18: 2350-2358. (Pubitemid 47203851)
6. Kim MJ, Tam FW (2011) Urinary monocyte chemoattractant protein-1 in renal disease. Clin Chim Acta 412: 2022-2030.
7. Lieberthal JG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, et al. (2013) Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis. J Rheumatol 40: 674-683.
8. Rosa RF, Takei K, Araujo NC, Loduca SM, Szajubok JC, et al. (2012) Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. J Rheumatol 39: 1948-1954.
9. Titan SM, Vieira JM, Jr., Dominguez WV, Moreira SR, Pereira AB, et al. (2012) Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy. J Diabetes Complications 26: 546-553.
10. Tofik R, Aziz R, Reda A, Rippe B, Bakoush O (2011) The value of IgG-uria in predicting renal failure in idiopathic glomerular diseases. A long-term follow-up study. Scand J Clin Lab Invest 71: 123-128.
11. Ohlsson S, Bakoush O, Tencer J, Torffvit O, Segelmark M (2009) Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis. Mediators Inflamm 2009: 584916.
12. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, et al. (2009) Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 55: 24-38.
13. Tencer J, Thysell H, Grubb A (1996) Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest 56: 691-700. (Pubitemid 27078204)
14. Price CP, Spencer K, Whicher J (1983) Light-scattering immunoassay of specific proteins: a review. Ann Clin Biochem 20 Pt 1: 1-14. (Pubitemid 13156952)
15. Svendsen P, Blirup-Jensen S (1991) Determination of human plasma proteins by turbidimetry and nephelometry. Copenhagen, Dako.
16. Bjork J, Back SE, Sterner G, Carlson J, Lindstrom V, et al. (2007) Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest 67: 678-695. (Pubitemid 350034643)
17. Nyman U, Bjork J, Sterner G, Back SE, Carlson J, et al. (2006) Standardization of p-creatinine assays and use of lean body mass allow improved prediction of calculated glomerular filtration rate in adults: a new equation. Scand J Clin Lab Invest 66: 451-468. (Pubitemid 44454442)
18. Nam BY, Paeng J, Kim SH, Lee SH, Kim do H, et al. (2012) The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions. Apoptosis 17: 1-13.
19. Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL (2009) Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 41: 998-1001.
20. Kim MJ, Tam FW (2011) Urinary monocyte chemoattractant protein-1 in renal disease. Clin Chim Acta 412: 2022-2030.
21. Barbado J, Martin D, Vega L, Almansa R, Goncalves L, et al. (2012) MCP-1 in urine as biomarker of disease activity in Systemic Lupus Erythematosus. Cytokine 60: 583-586.
22. Murea M, Register TC, Divers J, Bowden DW, Carr JJ, et al. (2012) Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study. BMC Nephrol 13: 148.
23. Titan SM, Vieira JM Jr., Dominguez WV, Moreira SR, Pereira AB, et al. (2012) Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy. J Diabetes Complications 26: 546-553.
24. Singh RG, Usha, Rathore SS, Behura SK, Singh NK (2012) Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 21: 1214-1218.
25. Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, et al. (2012) Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. J Nephrol 25: 810-818.
26. Anders HJ, Vielhauer V, Schlondorff D (2003) Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415. (Pubitemid 36126787)
27. Bakoush O, Grubb A, Rippe B, Tencer J (2001) Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria. Kidney Int 60: 1904-1909. (Pubitemid 32999996)
28. McQuarrie EP, Shakerdi L, Jardine AG, Fox JG, Mackinnon B (2011) Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritis. Nephrol Dial Transplant 26: 1563-1569.
29. Abbate M, Zoja C, Remuzzi G (2006) How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17: 2974-2984. (Pubitemid 44707757)
30. Yu C, Gong R, Rifai A, Tolbert EM, Dworkin LD (2007) Long-term, highdosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection. J Am Soc Nephrol 18: 750-759. (Pubitemid 46434492)